Haya Jamali

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Transforming Growth Factor

Chronic Lymphocytic Leukemia

Top Venues

Annals of the American Thoracic Society

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Haya Jamali, Andrew M Luks
What's the Difference Anyway? Annals of the American Thoracic Society 21 (4) (2024)
Haya Jamali, Andrew M Luks
Don't Be So Dense! Annals of the American Thoracic Society 20 (4) (2023)
Haya Jamali, David Wu, Lorinda Soma, Michael Linenberger, Mark H Wener, Lev Silberstein
Ibrutinib response in a patient with refractory mixed essential cryoglobulinemia. EJHaem 4 (2) (2023)
Haya Jamali, David Wu, Lorinda Soma, Michael Linenberger, Mark H Wener, Lev Silberstein
Ibrutinib response in a patient with refractory mixed essential cryoglobulinemia. EJHaem 4 (2) (2023)
Haya Jamali, David Wu, Lorinda Soma, Michael Linenberger, Mark H Wener, Lev Silberstein
Ibrutinib response in a patient with refractory mixed essential cryoglobulinemia. EJHaem 4 (2) (2023)
Haya Jamali, Lauren T Castillo, Chelsea Cosby Morgan, Jason Coult, Janice L Muhammad, Oyinkansola O Osobamiro, Elizabeth C Parsons, Rosemary Adamson
Racial Disparity in Oxygen Saturation Measurements by Pulse Oximetry: Evidence and Implications. Annals of the American Thoracic Society 19 (12) (2022)
Zachary T K Gannam, Kisuk Min, Shanelle R Shillingford, Lei Zhang, James Herrington, Laura Abriola, Peter C Gareiss, Georgios Pantouris, Argyrios Tzouvelekis, Naftali Kaminski, Xinbo Zhang, Jun Yu, Haya Jamali, Jonathan A Ellman, Elias J Lolis, Karen S Anderson, Anton M Bennett
An allosteric site on MKP5 reveals a strategy for small-molecule inhibition. Science signaling 13 (646) (2020)